The Effect of Compound Danshen Dripping Pills on the Dose and Concentration of Warfarin in Patients with Various Genetic Polymorphisms
-
Add time:07/13/2019 Source:sciencedirect.com
PurposeThe combination of warfarin and compound Danshen dripping pill (CDDP) is helpful for patients with both coronary heart disease (CHD) and atrial fibrillation (AF). The main adverse drug reaction of warfarin is bleeding because of its narrow therapeutic index. The safety of a combination therapy with warfarin and CDDP is always a concern. Our previous research showed that the combination of warfarin and CDDP improved the quality of life for patients with both CHD and AF. This study describes the changes in dose and concentration of warfarin necessary and evaluates bleeding risk when warfarin is given concomitantly with CDDP.
We also recommend Trading Suppliers and Manufacturers of (R)-7-Hydroxy Warfarin (cas 63740-76-1). Pls Click Website Link as below: cas 63740-76-1 suppliers
Prev:Additive manufacturing of personalized orodispersible warfarin films
Next:Maintenance dose of warfarin beyond time in therapeutic range for preventing vascular events) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS)07/20/2019
- Personalisation of warfarin therapy using thermal ink-jet printing07/21/2019
- Warfarin Use Is Associated With Progressive Coronary Arterial Calcification07/19/2019
- Monitoring unbound warfarin in drug combination therapy by pharmacokinetics and fluorospectrometry07/18/2019
- Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study07/17/2019
- Effect of genetic and patient factors on warfarin pharmacodynamics following warfarin withdrawal: Implications for patients undergoing surgery07/16/2019
- Warfarin-exposed zebrafish embryos resembles human warfarin embryopathy in a dose and developmental-time dependent manner – From molecular mechanisms to environmental concerns07/15/2019
- Maintenance dose of warfarin beyond time in therapeutic range for preventing vascular events07/14/2019
- Additive manufacturing of personalized orodispersible warfarin films07/12/2019
